Health Care: Drugs

Achillion Pharmaceuticals Inc (ACHN: NASDAQ)

$4.21 n/a | n/a%
05/26/17 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 4.21
52 Week High 10.06
52 Week Low 3.15
Avg. Daily Vol. (Mil) 1.37
Beta (3 year) 2.62
Share Related Items
Mkt Cap (Mil) 575.61
Shares Out (Mil) 136.72
Float (Mil) 115.81
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 35.70
Current Ratio 36.10
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 38.37
Price/Book 1.51
Price/Cash Flow -9.30
Per Share Data
Earnings -0.47
Sales 0.11
Book Value 2.80
Cash Flow -0.45
Business Summary
Achillion Pharmaceuticals Inc is a biopharmaceutical company which focuses on the discovery, development and commercialization of treatments for infectious diseases like hepatitis C virus, or HCV, infection that are once-daily and ribavirin-free.
General Information
300 George Street
New Haven, CT 06511
Industry : Drugs
Sector: Health Care
Employees: 81
CEO: Milind S. Deshpande,PhD
Short Interest
Current Month (Mil) 9.25
Previous Month (Mil) 10.50
Short Interest Ratio (Days) 7.30
Management Effectiveness
Return on Equity n.a.
Return on Assets -16.20
Return on Investments -16.70
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with ACHN

Latest ACHN Headlines from TheStreet

More Financial News for ACHN

Press Releases for ACHN

See All Press Releases

Partner Headlines for ACHN

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter